An Observational Study to Evaluate the Treatment of Newvast® Tab(Atorvastatin) in Korean Patients With Dyslipidemia
Clinical trial NCT05555238 · COMPLETED
Trial details
- NCT number
- NCT05555238
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-01-16
- Primary completion
- 2022-01-27
- Enrollment
- 1716
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.